FOND IRCCS ISTITUTO NAZ DEI TUMORI has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Italy and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are HANSON PETER, ORDWAY RES INST INC and CENTRO DE INVESTIG Y DESARROLLO DE MEDICAMENTOS CIDEM.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Italy | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Sozzi Gabriella | 3 |
#2 | Pastorino Ugo | 3 |
#3 | Boeri Mattia | 3 |
#4 | Gianni Alessandro Massimo | 2 |
#5 | Raspagliesi Francesco | 2 |
#6 | Carlo-Stella Carmelo | 2 |
#7 | Cirrincione Girolamo | 1 |
#8 | Niccolini Elisa | 1 |
#9 | Appierto Valentina | 1 |
#10 | Bellone Matteo | 1 |
Publication | Filing date | Title |
---|---|---|
EP2548555A1 | Proton pump inhibitors as immunomodulators | |
WO2012013229A1 | Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system. | |
EP2419103A1 | Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability | |
EP2167448A1 | Purification procedure for the preparation of the radioactive tracer 3' -desoxy-3' - [18]-fluorothymidine ([18f]flt) |